Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease.
about
The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel DiseaseMotilin receptor density in inflamed and noninflamed tissue in rabbit TNBS-induced colitis.Neurochemical coding in the small intestine of patients with Crohn's disease.Some aspects of neuroendocrine pathology.Consequences of intestinal inflammation on the enteric nervous system: neuronal activation induced by inflammatory mediators.Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis.Oesophageal epithelial innervation in health and reflux oesophagitis.Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paperChanges in chemical coding of myenteric neurones in ulcerative colitisVIP immunoreactive nerves and somatostatin and serotonin containing cells in Crohn's diseaseInfluence of renovascular hypertension on the distribution of vasoactive intestinal peptide in the stomach and heart of rats.Regulation of proliferation of human colonic subepithelial myofibroblasts by mediators important in intestinal inflammation.Homeostatic and therapeutic roles of VIP in smooth muscle function: myo-neuroimmune interactions.Distribution and localization of regulatory peptides.Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation.Breaking human cytomegalovirus major immediate-early gene silence by vasoactive intestinal peptide stimulation of the protein kinase A-CREB-TORC2 signaling cascade in human pluripotent embryonal NTera2 cells.Neuroendocrine disorders of the gut.Organelle pathology in ulcerative and Crohn's colitis with special reference to the lysosomal alterations.Analysis of innervation of human mesenteric vessels in non-inflamed and inflamed bowel--a confocal and functional study.Distribution of calcitonin gene-related peptide, somatostatin, substance P and vasoactive intestinal polypeptide in experimental colitis in rats.Modulation of VIPergic phenotype of enteric neurons by colonic biopsy supernatants from patients with inflammatory bowel diseases: Involvement of IL-6 in Crohn's disease.Neuroendocrine changes in colon of mice with a disrupted IL-2 gene.
P2860
Q26774660-65E25E56-687C-4C32-BB14-A457565BF208Q31907364-74141FD3-22A0-4A0D-B03D-865DC2071E10Q33618209-DE00919C-CCBB-4762-B7FC-CF2681FF482CQ33838204-E6A89D55-28D7-4754-9E5C-CBD0EEA34AE3Q34123459-EBC3CE03-94C6-49DA-A658-1DC7BDA0DEF2Q34979549-232546B9-3FAF-44CC-90DD-5C5833DC53E7Q35354440-8EC88C0C-FC5F-4340-90C3-10EB02F54C9AQ35359745-094885E1-3BCC-460C-B048-5E8F45BCDB95Q35595304-D53FCAD3-84E2-4FB4-B719-F21A13753F8DQ36397602-4A055E99-0850-4DD3-B78F-F100449FF7A5Q37071198-11BB0BE9-01B3-443F-87BA-6CFB30609300Q37383198-C375787E-FD52-413C-AF92-772D6C2D3F00Q37391804-60EE6B5A-DCA6-4E4B-A0B0-49C450F1DE1CQ38152772-5366CF6B-83A3-482D-8177-AC780B6F63F3Q38622923-C4E6B906-AA67-47F8-B6A3-F42C9F596B81Q39308242-D1075624-F906-4BF6-AC93-D590F1478ABFQ39860663-369FD507-A7DD-4C15-B0A4-55D7D5CE5559Q40245760-1EBA2BA8-FDAC-477E-8100-AC4650EB4EB1Q42112922-BBD78346-404C-4D51-955C-D95C488EE8D1Q46734991-06BE41CB-9D22-40D0-872A-CF7F65C44965Q47715809-D60FDDB8-3E93-4279-8668-81AE70D7E825Q47817542-C9037848-B9FA-4E84-88CC-8D0167C0C055Q52539519-B63ECB3B-FA38-41A4-83FD-90379B179D01
P2860
Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh-hant
name
Vasoactive intestinal peptide ...... th inflammatory bowel disease.
@en
Vasoactive intestinal peptide ...... th inflammatory bowel disease.
@nl
type
label
Vasoactive intestinal peptide ...... th inflammatory bowel disease.
@en
Vasoactive intestinal peptide ...... th inflammatory bowel disease.
@nl
prefLabel
Vasoactive intestinal peptide ...... th inflammatory bowel disease.
@en
Vasoactive intestinal peptide ...... th inflammatory bowel disease.
@nl
P2093
P2860
P356
P1433
P1476
Vasoactive intestinal peptide ...... th inflammatory bowel disease.
@en
P2093
McGregor GP
O'Morain C
P2860
P356
10.1136/GUT.25.1.57
P407
P577
1984-01-01T00:00:00Z